机译:老年糖尿病患者的治疗选择:开放标签,口服抗糖尿病药物中加入甘精胰岛素的随机临床试验与增加口服抗糖尿病药物的剂量
Department of Internal Medicine University of Catania Ospedale Garibaldi Nesima Via Palermo 636 95122 Catania Italy;
U.O. of Geriatry Catania Italy;
U.O. of Diabetology Ospedale Cannizzaro Catania Italy;
U.O. of Diabetology Ospedale Cannizzaro Catania Italy;
U.O. of Geriatry Catania Italy;
U.O. of Geriatry Catania Italy;
Department of Internal Medicine University of Catania Ospedale Garibaldi Nesima Via Palermo 636 95122 Catania Italy;
Department of Internal Medicine University of Catania Ospedale Garibaldi Nesima Via Palermo 636 95122 Catania Italy;
Department of Internal Medicine University of Catania Ospedale Garibaldi Nesima Via Palermo 636 95122 Catania Italy;
Department of Internal Medicine University of Catania Ospedale Garibaldi Nesima Via Palermo 636 95122 Catania Italy;
Department of Internal Medicine University of Catania Ospedale Garibaldi Nesima Via Palermo 636 95122 Catania Italy;
Department of Internal Medicine University of Catania Ospedale Garibaldi Nesima Via Palermo 636 95122 Catania Italy;
Type 2 diabetes; Elderly; Hypoglycemia; Glargine; Oral antidiabetics;
机译:老年糖尿病患者的治疗选择:开放标签,将甘精胰岛素加入口服抗糖尿病药物与增加口服抗糖尿病药物剂量的随机临床试验。
机译:疗效和安全性为1:1胰岛素狼氨酰胺和Lixisenatide与日本2型糖尿病患者的Lixisenatide在口腔抗糖尿病药物上不充分控制:Lixilan JP-O1随机临床试验
机译:甘精胰岛素与预混胰岛素治疗未使用口服抗糖尿病药物的初治2型糖尿病糖尿病的比较:开放标签,随机GALAPAGOS研究
机译:生物相容性互聚合物复合基质片剂 - 口服持续释放类药物抗糖尿病药物
机译:在口服抗糖尿病药物控制不佳的日本2型糖尿病患者中胰岛素甘精胰岛素和利西拉来比与利西拉来比1:1固定比例联合使用的有效性和安全性:LixiLan JP-O1随机临床试验
机译:疗效和安全性为1:1固定比率组合(Iglarllixi)与日本患者患者的二仙肽与口腔抗糖尿病药物2型糖尿病患者(Iglarlarlix)与Lixisenate患者在口腔抗糖尿病药物中进行:Lixilan JP-O1随机临床试验